FORMULATION DEVELOPMENT, OPTIMIZATION, AND EVALUATION OF LANSOPRAZOLE LOADED NANOSUSPENSION

LALITA S. NEMADE; MORESHWAR P. PATIL

doi:10.22159/ijap.2023v15i3.47327

Authors

LALITA S. NEMADE Department of Pharmaceutics, MET Institute of Pharmacy Adgaon, Nashik-422003, Maharashtra, India https://orcid.org/0009-0008-9306-7218
MORESHWAR P. PATIL Department of Pharmaceutics, MET Institute of Pharmacy Adgaon, Nashik-422003, Maharashtra, India https://orcid.org/0000-0002-8060-1687

DOI:

https://doi.org/10.22159/ijap.2023v15i3.47327

Keywords:

Lansoprazole, Nanopure method, Nanosuspension, Drug release, Solubility, Stability

Abstract

Objective: To address issues with drug release, manufacturing, and drug product stability, the primary objective of this study was to optimize the solubility of poorly soluble lansoprazole medication by using an appropriate nanosuspension formulation.

Methods: The freeze-drying (nanopure) method was used to create lansoprazole nanosuspensions. The formulation and process variables affecting the properties of nanosuspensions (mannitol concentration, drug concentration, and PVP-K30 concentration) were optimized. Particle size, shape, zeta potential, drug content, stability study, and in vitro drug release study were performed on the nanosuspensions.

Results: Out of different batches of nanosuspension, batch F4 displayed the most optimizing parameters, i.e., drug content 97±1.2%, average particle size 125.5 nm, polydispersity index 0.361, and zeta potential-22.7 mV. In comparison to other formulations, the PVP-K30 polymer in F4 demonstrated an effective cumulative drug release of 120 min. In stability studies, optimized nanosuspension displayed favorable results and demonstrated significant stability for the said period of time.

Conclusion: The most promising drug release profile was shown by the optimized (F4) nanosuspension, which also demonstrated increased lansoprazole solubility. We have concluded from the current study that nanosuspension can serve as a better formulation for lansoprazole delivery.

Downloads

Download data is not yet available.

Author Biography

MORESHWAR P. PATIL, Department of Pharmaceutics, MET Institute of Pharmacy Adgaon, Nashik-422003, Maharashtra, India

References

Sharma P, Denny WA, Garg S. Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm. 2009 Oct 1;380(1-2):40-8. doi: 10.1016/j.ijpharm.2009.06.029, PMID 19576976.

Aher SS, Malsane ST, Saudagar RB. Nanosuspension: an overview. Int J Curr Pharm Sci. 2017;9(3):19-23. doi: 10.22159/ijcpr.2017.v9i3.19584.

Verma S, Lan Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009;377(1-2):185-98. doi: 10.1016/j.ijpharm.2009.05.006, PMID 19446617.

VDN S, SVN P. Nanosuspensions: a promising drug delivery systems. Int J Pharm Sci Nanotechnol. 2009;2(4):679-84.

Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56(7):827-40. doi: 10.1211/0022357023691, PMID 15233860.

Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785-96. doi: 10.1038/nrd1494, PMID 15340388.

Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172(3):1126-41. doi: 10.1016/j.jconrel.2013.08.006, PMID 23954372.

Wang L, Du J, Zhou Y, Wang Y. Safety of nanosuspensions in drug delivery. Nanomedicine. 2017;13(2):455-69. doi: 10.1016/j.nano.2016.08.007, PMID 27558350.

Barradell LB, Faulds D, McTavish D. Lansoprazole a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs. 1992;44(2):225-50. doi: 10.2165/00003495-199244020-00007, PMID 1382017.

Fort FL, Miyajima H, Ando T, Suzuki T, Yamamoto M, Hamashima T. Mechanism for species-specific induction of leydig cell tumors in rats by lansoprazole. Fundam Appl Toxicol. 1995;26(2):191-202. doi: 10.1006/faat.1995.1090, PMID 7589908.

Hishinuma T, Suzuki K, Yamaguchi H, Yamagishi H, Koike T, Ohara S. Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;870(1):38-45. doi: 10.1016/j.jchromb.2008.05.034, PMID 18555753.

Kasture SV, Gondkar SB, Darekar AB, Priyobrata D, Bhambar KV. Enhancement of dissolution rate of lansoprazole using liquisolid tablet technique. Int J Pharm Res. 2011;3(2):27-31.

Landes BD, Petite JP, Flouvat B. Clinical pharmacokinetics of lansoprazole. Clin Pharmacokinet. 1995;28(6):458-70. doi: 10.2165/00003088-199528060-00004, PMID 7656504.

Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62(1):3-16. doi: 10.1016/j.ejpb.2005.05.009, PMID 16129588.

Nida DL, Rahman MS, Carlson KD, Richards Kortum R, Follen M. Fluorescent nanocrystals for use in early cervical cancer detection. Gynecol Oncol. 2005;99(3) Suppl 1:S89-94. doi: 10.1016/j.ygyno.2005.07.050, PMID 16139342.

Özaltín N. Determination of lansoprazole in pharmaceutical dosage forms by two different spectroscopic methods. J Pharm Biomed Anal. 1999;20(3):599-606. doi: 10.1016/s0731-7085(99)00061-8, PMID 10701978.

Geetha G, Poojitha U, Khan KAA. Various techniques for preparation of nanosuspension-a review. Int J Pharm Res Rev. 2014;3(9):30-7.

Vedaga SB, Gondkar SB, Saudagar RB. Nanosuspension: an emerging trend to improve the solubility of poorly water-soluble drugs. J Drug Deliv Ther. 2019;9(3):549-53.

Vittal GV, Deveswaran R, Bharath S, Basavaraj B, Madhavan V. Formulation and characterization of ketoprofen liquisolid compacts by box-behnken design. Int J Pharm Investig. 2012;2(3):150-6. doi: 10.4103/2230-973X.104398, PMID 23373006.

Ferreira SLC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC. Box-behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 2007;597(2):179-86. doi: 10.1016/j.aca.2007.07.011, PMID 17683728.

Robinson TJ. Box-behnken designs. Wiley STATS Ref Stat Ref Online; 2014.

Zhang TF, Yang JF, Lin DKJ. Small box-behnken design. Stat Probab Lett. 2011;81(8):1027-33. doi: 10.1016/j.spl.2011.02.024.

Almeida MO, Barros DAS, Araujo SC, Faria SHDM, Maltarollo VG, Honorio KM. Study on molecular structure, spectroscopic properties (FTIR and UV–vis), NBO, QTAIM, HOMO-LUMO energies and docking studies of 5-fluorouracil, a substance used to treat cancer. Spectrochim Acta A Mol Biomol Spectrosc. 2017;184:169-76. doi: 10.1016/j.saa.2017.04.070, PMID 28494379.

Menczel JD, Judovits L, Prime RB, Bair HE, Reading M, Swier S. Differential scanning calorimetry (DSC). Therm Anal Polym Fundam Appl. 2008:7-239.

Epp J. X-ray diffraction (XRD) techniques for materials characterization materials characterization using nondestructive evaluation (NDE). Methods. 2016:81-124.

Erdman N, Bell DC, Reichelt R. Scanning electron microscopy. In: Springer handbooks; 2019. p. 229-318. doi: 10.1007/978-3-030-00069-1_5.

Hsieh YL, Taylor LS. Salt stability-effect of particle size, relative humidity, temperature and composition on salt to free base conversion. Pharm Res. 2015;32(2):549-61. doi: 10.1007/s11095-014-1484-2, PMID 25145335.

Siddiqui N, Rauf A, Latif A, Mahmood Z. Spectrophotometric determination of the total phenolic content, spectral and fluorescence study of the herbal unani drug gul-e-zoofa (Nepeta bracteata Benth). J Taibah Univ Med Sci. 2017;12(4):360-3. doi: 10.1016/j.jtumed.2016.11.006, PMID 31435264.

Mischenko SV, Mordasov MM, Savenkov AP, Sychev VA. Analysis of the influence of sizes of a vessel with a liquid on the readings of Brookfield viscometer. Meas Tech. 2020;63(4):288-94. doi: 10.1007/s11018-020-01784-2.

Frank KJ, Rosenblatt KM, Westedt U, Holig P, Rosenberg J, Magerlein M. Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement. Int J Pharm. 2012;437(1-2):288-93. doi: 10.1016/j.ijpharm.2012.08.014, PMID 22951865.

Batheja P, Sheihet L, Kohn J, Singer AJ, Michniak Kohn B. Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies. J Control Release. 2011;149(2):159-67. doi: 10.1016/j.jconrel.2010.10.005, PMID 20950659.

Galey WR, Lonsdale HK, Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J Invest Dermatol. 1976;67(6):713-7. doi: 10.1111/1523-1747.ep12598596, PMID 1033956.

Dasari V, Shaikh A, Sisodiya D, Bhargava T, Dangi R, Nagwe S. Stability study of mucoadhesive microsphere containing nateglinide by using biodegradable polymer chitosan. J Pharm Res Int. 2021:866-72. doi: 10.9734/jpri/2021/v33i47A33086.

Tiwari V, Kumar BMN, Sharma V, Gautam DNS. Accelerated stability study and quantitative estimation of piperine in draksharishta. Int J Res Pharm Sci. 2017;8(2):209-15.

Awasthi R, Manchanda S, Das P, Velu V, Malipeddi H, Pabreja K. Poly(vinylpyrrolidone). Inengineering of biomaterials for drug delivery systems. Woodhead Publishing; 2018. p. 255-72.

Moschwitzer J, Muller RH. Drug nanocrystals-the universal formulation approach for poorly soluble drugs. In: Nanoparticulate drug delivery systems. CRC Press; 2007. p. 71-88. doi: 10.1201/9781420008449.ch5.